Cristian Massacesi - 01 Aug 2026 Form 4 Insider Report for BRISTOL MYERS SQUIBB CO (BMY)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
04 Aug 2026, 16:10:21 UTC
Prior SEC filing
12 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Amy Fallone, attorney-in-fact for Cristian Massacesi

Key filing fact

Cristian Massacesi filed Form 4 for BRISTOL MYERS SQUIBB CO (BMY) on 04 Aug 2026.

Key facts

  • This page summarizes Cristian Massacesi's Form 4 filing for BRISTOL MYERS SQUIBB CO (BMY).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 04 Aug 2026, 16:10.

Change

  • Previous filing in this sequence was filed on 12 Mar 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002080176 Primary reporting owner

Massacesi Cristian

Relationship
EVP,Chief Med Offr,Head of Dev
Address
BRISTOL-MYERS SQUIBB COMPANY, ROUTE 206 AND PROVINCE LINE ROAD, PRINCETON
Signature
/s/ Amy Fallone, attorney-in-fact for Cristian Massacesi
Signature date
04 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BMY transaction

Common Stock, $0.10 par value

Options Exercise

Transaction value
Shares
+51,172
Change %
Price
$0.000000*
Shares after
51,172
Date
01 Aug 2026
Ownership
Direct
Footnotes
F1
BMY transaction

Common Stock, $0.10 par value

Tax liability

Transaction value
Shares
-26,175
Change %
-51%
Price
$65.31*
Shares after
24,997
Date
01 Aug 2026
Ownership
Direct
Footnotes
F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BMY transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares
-51,172
Change %
-25%
Price
$0.000000*
Shares after
153,519
Date
01 Aug 2026
Ownership
Direct
Underlying class
Common Stock, $0.10 par value
Underlying amount
51,172
Exercise price
Footnotes
F1, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The restricted share units will vest in four equal annual installments on the first, second, third, and fourth anniversaries of the grant date.

Footnote F2

Shares withheld for payment of taxes upon vesting of awards.

Footnote F3

Each restricted stock unit converts into one share of common stock upon vesting.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .